Skip to content
The Policy VaultThe Policy Vault

Victoza (liraglutide)United Healthcare

Type 2 diabetes mellitus

Initial criteria

  • Submission of medical records (e.g., chart notes) confirming diagnosis of type 2 diabetes mellitus as evidenced by one of the following laboratory values:
  • – A1C ≥ 6.5%
  • – Fasting plasma glucose (FPG) ≥ 126 mg/dL
  • – 2-hour plasma glucose (PG) ≥ 200 mg/dL during oral glucose tolerance test
  • – Random plasma glucose ≥ 200 mg/dL in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis
  • OR
  • For patients requiring ongoing treatment for type 2 diabetes mellitus (diagnosed > 2 years ago), submission of medical records confirming diagnosis of type 2 diabetes mellitus
  • Medication not prescribed for weight loss

Approval duration

12 months